Regulatory Landscape Newsletter – August 2019

We saw regulatory hiring slow down slightly in July, which is fairly normal for the summer. There is still a high demand for Regulatory CMC, Regulatory Strategy, and Regulatory Advertising & Promotions professionals at all levels across the country. Hiring remains strong in the SF Bay Area and the Boston/Cambridge market. In July Dennis Partners[…]

Top Regulatory News Stories – Week Ending August 2, 2019

Celgene received FDA approval for Otezla to treat oral ulcers associated with Behçet’s Disease. Apic Bio, Inc. announced that the FDA has granted orphan drug designation to APB-102, a gene therapy soon to be in clinical development for the treatment of genetic SOD1 amyotrophic lateral sclerosis (ALS). Biohaven Pharmaceuticals reported that the FDA[…]